Formation of mono- and dual-labelled antibody fragment conjugates via reversible site-selective disulfide modification and proximity induced lysine reactivity

Ioanna A. Thanasi, Nathalie Bouloc, Clíona McMahon, Ning Wang, Peter A. Szijj, Tobias Butcher, Léa N. C. Rochet, Elizabeth A. Love, Andy Merritt, James R. Baker and Vijay Chudasama

Chem. Sci., 2025, 16, 2763
DOI: 10.1039/D4SC06500J

Chemical technology principles for selective bioconjugation of proteins and antibodies

Preeti Chauhan, Ragendu V., Mohan Kumar, Rajib Molla, Surya Dev Mishra, Sneha Basa and Vishal Rai

Chem. Soc. Rev., 2024, 53, 380
DOI: 10.1039/D3CS00715D

Breaking the bottlenecks in nanozyme–antibody conjugate preparation: challenges, optimization strategies, and applications of in vitro diagnostics

Kehui Yu, Mengjun Wang, Haoan Wu, Ming Ma and Yu Zhang

Anal. Methods, 2026
DOI: 10.1039/D6AY00209A

An MMAE-loaded PDL1 active targeting nanomedicine for the precision treatment of colon cancer

Zhenqian Zhang, Honglei Zhang, Linjie Cui, Xiaoshuang Wang, Di Wang, Zhilin Liu, Xuefei Zhang and Zhaohui Tang

Biomater. Sci., 2023, 11, 5195
DOI: 10.1039/D3BM00664F

Chemo- and regio-selective differential modification of native cysteines on an antibody via the use of dehydroalanine forming reagents

Steven Y. Yap, Tobias Butcher, Richard J. Spears, Clíona McMahon, Ioanna A. Thanasi, James R. Baker and Vijay Chudasama

Chem. Sci., 2024, 15, 8557
DOI: 10.1039/D4SC00392F

Enabling the synthesis of multi-payload thio-antibody conjugates through the use of pyridazinediones, p-anisidine derivatives and various click chemistries

Clíona McMahon, Christophe J. Queval, Ioanna A. Thanasi, Dawn H. W. Lau, Michael Howell, Ning Wang, Maximillian T. W. Lee, Josephine S. Gaynord, James R. Baker and Vijay Chudasama

RSC Chem. Biol., 2026, 7, 656
DOI: 10.1039/D6CB00018E

The role of hydrophilic linkers in next-generation antibody-drug conjugates

Qiang Fu, Xueqing Kong, Yisong Liu, Meitong Liu, Kun Huang, Peng George Wang and Kui Wu

Journal of Controlled Release, 2026, 391, 114612
DOI: 10.1016/j.jconrel.2026.114612

Anti-tumor efficacy and Vδ2 T-cell activation via EGFR antibody-drug conjugates featuring novel aminobisphosphonates

Doretta Cuffaro, Linda Di Gregorio, Camilla Mangini, Martina Taglieri, Serena Matis, Roberto Benelli, Massimo Ardy, Laura Salvini, Armando Rossello, Alessandro Poggi, Lizzia Raffaghello and Elisa Nuti

Sci Rep, 2025, 15
DOI: 10.1038/s41598-025-22669-w

SNAP-Tag-Based Antibody–Drug Conjugates Targeting Epidermal Growth Factor Receptor 1, Epidermal Growth Factor Receptor 2, Trophoblast Cell-Surface Antigen 2, and Tissue Factor for Ovarian Cancer Treatment

Chaoyu Zhang, Wenjie Sheng, T. M. Mohiuddin, Marwah Al-Rawe, Roland Schmitz, Marcus Niebert, Felix Zeppernick, Ivo Meinhold-Heerlein and Ahmad Fawzi Hussain

ACS Omega, 2026, 11, 17393
DOI: 10.1021/acsomega.5c10377

Synthesis and evaluation of antibody-drug conjugates with high drug-to-antibody ratio using dimaleimide-DM1 as a linker- payload

Joo-Hyun Jeon, Seo Woo Kim, Yoon-Jung Kim, Jang-Woo Park, Jee Eun Moon, Yong Beom Lee, Hana Yu, Geon-Ho Lee, Sung-Ha Jin and Jin-Hyun Jeong

Bioorganic Chemistry, 2024, 149, 107504
DOI: 10.1016/j.bioorg.2024.107504

Site-Specific Dolasynthen Antibody–Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios

Susan M. Clardy, Alex Uttard, Bingfan Du, Kalli C. Catcott, Kelly L. Lancaster, Elizabeth Ditty, Jack Sadowsky, Jeffrey Zurita, Naniye Malli, LiuLiang Qin, Stephen P. Bradley, Kenneth Avocetien, Tyler Carter, Dokyong Kim, Mark Nazzaro, Ling Xu, Thomas H. Pillow, Neelie T. Zacharias, Gail D. Lewis, Rebecca K. Rowntree, Radha Iyengar, David H. Lee, Marc Damelin, Dorin Toader and Timothy B. Lowinger

Molecular Cancer Therapeutics, 2024, 23, 84
DOI: 10.1158/1535-7163.MCT-23-0262

CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells

Kelly C. Arias Cardenas, Clinton W. Enos, Mark R. Spear, Dana E. Austin, Raghad Almofeez, Stephanie Kortchak, Lauren Pincus, Hua-bei Guo, Samuel Dolezal, J. Michael Pierce, Emma Furth, Cyrille Gineste, Yongjun Kwon and Cohava Gelber

CCDT, 2024, 24, 720
DOI: 10.2174/0115680096260614231115192343

Research Progress of Antibody-Oligonucleotide Conjugates

瑶孙

PI, 2024, 13, 82
DOI: 10.12677/PI.2024.132011

Targeted Drug Delivery Using a Plug-to-Direct Antibody–Nanogel Conjugate

Uyen Huynh, Peidong Wu, Jingyi Qiu, Theeraphop Prachyathipsakul, Khushboo Singh, D. Joseph Jerry, Jingjing Gao and S. Thayumanavan

Biomacromolecules, 2023, 24, 849
DOI: 10.1021/acs.biomac.2c01269

Exploration of the antibody–drug conjugate clinical landscape

Heather Maecker, Vidya Jonnalagadda, Sunil Bhakta, Vasu Jammalamadaka and Jagath R. Junutula

mAbs, 2023, 15
DOI: 10.1080/19420862.2023.2229101

Regulated bioanalysis of antibody-drug conjugates using LC-MS

Katsunori Ieki, Suguru Fukuda, Shiori Miyawaki and Kazunari Hirowatari

Bioanalysis, 2025, 17, 549
DOI: 10.1080/17576180.2025.2490468

Targeted therapies in bladder cancer: signaling pathways, applications, and challenges

Mei Peng, Xuetong Chu, Yan Peng, Duo Li, Zhirong Zhang, Weifan Wang, Xiaochen Zhou, Di Xiao and Xiaoping Yang

MedComm, 2023, 4
DOI: 10.1002/mco2.455

Site-Specific Glycan Conjugation Improves Stability and Efficacy of an Antibody–Drug Conjugates Bearing DXd as a Cytotoxic Payload

Shino Manabe, Shogo Senga, Shogo Iwamoto, Hikaru Yarita, Ryo Takahashi, Ai Mitani, Wataru Sumiyoshi, Asako Hoshinoo, Methanee Hiranyakorn, Takashi Kinoshita and Chihoko Yoshimura

ACS Omega, 2026, 11, 13459
DOI: 10.1021/acsomega.5c10898

An Antibody‐Drug Conjugate for Multiple Myeloma Prepared by Multi‐Arm Linkers

Yueh‐Hsiang Yu, Wei‐Ting Tian, Cédric Grauffel, Wei‐Chen Lin, Ming‐Yu Hsieh, Pei‐Wen Wu, Hui‐Ju Lee, Chi‐Jiun Peng, Pei‐Hsuan Lin, Hsing‐Mao Chu, Carmay Lim and Tse Wen Chang

Advanced Science, 2024, 11
DOI: 10.1002/advs.202307852

Nanobody-drug conjugates as versatile tools for improving therapeutic potential

Sneha Banerjee, Anna Mariya, Sreeja Vangapally and Bhaskar Paidimuddala

Biochemical Engineering Journal, 2026, 228, 110072
DOI: 10.1016/j.bej.2026.110072

Antibiotic conjugates: Using molecular Trojan Horses to overcome drug resistance

Xi Li, Siyuan Dong, Qi Pan, Ning Liu and Yijie Zhang

Biomedicine & Pharmacotherapy, 2025, 186, 118007
DOI: 10.1016/j.biopha.2025.118007

Unstructured polypeptides as a versatile drug delivery technology

Yue Ji, Dingkang Liu, Haichao Zhu, Lichen Bao, Ruilong Chang, Xiangdong Gao and Jun Yin

Acta Biomaterialia, 2023, 164, 74
DOI: 10.1016/j.actbio.2023.04.019

Organic‐Solvent‐Free “Lego‐Like” Modular Preparation of Fab‐Nondestructive Antibody‐Drug Conjugates with Ultrahigh Drug‐to‐Antibody Ratio

Zhilin Liu, Honglei Zhang, Jiali Sun, Mengfei Zheng, Linjie Cui, Yu Zhang, Jianjun Cheng, Zhaohui Tang and Xuesi Chen

Advanced Materials, 2023, 35
DOI: 10.1002/adma.202300377

Optimizing Conjugation Chemistry, Antibody Conjugation Site, and Surface Density in Antibody–Nanogel Conjugates (ANCs) for Cell-Specific Drug Delivery

Peidong Wu, Theeraphop Prachyathipsakul, Uyen Huynh, Jingyi Qiu, D. Joseph Jerry and S. Thayumanavan

Bioconjugate Chem., 2023
DOI: 10.1021/acs.bioconjchem.3c00034

Mechanistic Characterization of the Potency of THIOMAB Antibody–Drug Conjugates Targeting Staphylococcus aureus and ETbR-Expressing Tumor Cells Using Quantitative LC-MS/MS Analysis of Intracellular Drug Accumulation

Hilda Hernandez-Barry, Josefa dela Cruz-Chuh, Kimberly K. Kajihara, Jyoti Asundi, Richard Vandlen, Donglu Zhang, Wouter L.W. Hazenbos, Thomas Pillow, Yichin Liu, Cong Wu, Katherine R. Kozak and Kelly M. Loyet

Bioconjugate Chem., 2025, 36, 652
DOI: 10.1021/acs.bioconjchem.4c00533

Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges

Abhavya Raja, Abhishek Kasana and Vaishali Verma

Mol Biotechnol, 2025, 67, 3345
DOI: 10.1007/s12033-024-01270-y

Chemical evolution of antibody–drug conjugates focused on linker design and conjugation strategies in hematology

Seungbin Park, Geetanjali B. Gone, Dohee Ahn and Sang J. Chung

Seminars in Hematology, 2025, 62, 289
DOI: 10.1053/j.seminhematol.2025.11.004

Polypeptides as alternatives to PEGylation of therapeutic agents

Huali Chen and Qianyu Zhang

Expert Opinion on Drug Delivery, 2024, 21, 1
DOI: 10.1080/17425247.2023.2297937

A review of conjugation technologies for antibody drug conjugates

Qirui Fan, Hu Chen, Guoguang Wei, Ding Wei, Zekun Wang, Lin Zhang, Jun Wang and Marie Zhu

Antibody Therapeutics, 2025, 8, 157
DOI: 10.1093/abt/tbaf010

Preparation of trastuzumab-DM1 conjugate with a high drug-to-antibody ratio for breast cancer therapy

Honglei Zhang, Zhenqian Zhang, Xiaoshuang Wang, Di Wang, Hang Xu, Zhilin Liu, Xuefei Zhang, Zhaohui Tang and Xuesi Chen

Nano Today, 2024, 54, 102134
DOI: 10.1016/j.nantod.2023.102134

What are the challenges involved in the strategies for future antibody-drug conjugate discovery and development for oncology?

Sajeli Ahil Begum and Ahmed Kamal

Expert Opinion on Drug Discovery, 2023, 18, 591
DOI: 10.1080/17460441.2023.2203910

Nanobody-Mediated Cellular Uptake Maximizes the Potency of Polylysine Dendrimers While Preserving Solid Tumor Penetration

Daniel Yuen, Orlagh M. Feeney, Leo Noi, Sudhir Shengule, Victoria M. McLeod, Pauline Reitano, Sammi Tsegay, Richard Hufton, Zachary H Houston, Nicholas L. Fletcher, James Humphries, Kristofer J. Thurecht, Carleen Cullinane, David J. Owen, Christopher J.H. Porter and Angus P.R. Johnston

ACS Nano, 2025, 19, 6044
DOI: 10.1021/acsnano.4c10851

Recent advances in bispecific antibody-drug conjugates for breast cancer therapy

Xuan Ji, Yalong Yang, Cong Ma, Wenqin Huang, Senyang Guo, Lingzi Wang, Hongmei Zheng and Xinhong Wu

Cancer Chemother Pharmacol, 2026, 96
DOI: 10.1007/s00280-025-04863-9

Targeting prostate cancer with site-specific antibody-drug conjugates enabled by tandemly fused ADP-ribosyl cyclases

Lei Zhang, Mashael F. Aldossari, Arshad J. Ansari, Guoyun Kao, Sunny H. Kim, Thuc Oanh Hoang, Kaiyu Shen, Zeyu Zhang, Srinivasarao Singireddi, Zekun Li, Yuanteng Zhao, Po-Wen Yu, Fariborz Nasertorabi, Benjamin B. Katz, Ling Li and Yong Zhang

Biomedicine & Pharmacotherapy, 2025, 189, 118274
DOI: 10.1016/j.biopha.2025.118274

Alternative therapeutic strategies to treat antibiotic-resistant pathogens

Craig R. MacNair, Steven T. Rutherford and Man-Wah Tan

Nat Rev Microbiol, 2024, 22, 262
DOI: 10.1038/s41579-023-00993-0

Antibody-Drug Conjugates: A promising breakthrough in cancer therapy

Swapnali Parit, Ajit Manchare, Amol D. Gholap, Prashant Mundhe, Navnath Hatvate, Satish Rojekar and Vandana Patravale

International Journal of Pharmaceutics, 2024, 659, 124211
DOI: 10.1016/j.ijpharm.2024.124211

Bispecific antibody drug conjugates: Making 1+1>2

Yilin Gu, Zhijia Wang and Yuxi Wang

Acta Pharmaceutica Sinica B, 2024, 14, 1965
DOI: 10.1016/j.apsb.2024.01.009

Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies

Yutaka Matsuda, Jenny R. Chang and Brian A. Mendelsohn

ChemBioChem, 2025, 26
DOI: 10.1002/cbic.202500305

Antibody–drug conjugates in cancer therapy: current landscape, challenges, and future directions

Bonan Chen, Xiaohong Zheng, Jialin Wu, Guoming Chen, Jun Yu, Yi Xu, William K. K. Wu, Gary M. K. Tse, Ka Fai To and Wei Kang

Mol Cancer, 2025, 24
DOI: 10.1186/s12943-025-02489-2

Antibody–Drug Conjugates in Hematological Malignancies: Current Landscape and Future Perspectives

Maria Chiara Montalbano, Matilde Micillo, Silvia Deaglio and Tiziana Vaisitti

IJMS, 2026, 27, 1025
DOI: 10.3390/ijms27021025

Recombinant protein polymer-antibody conjugates for applications in nanotechnology and biomedicine

Antonio G. Goncalves, Emily J. Hartzell, Millicent O. Sullivan and Wilfred Chen

Advanced Drug Delivery Reviews, 2022, 191, 114570
DOI: 10.1016/j.addr.2022.114570

Specific peptide conjugation to a therapeutic antibody leads to enhanced therapeutic potency and thermal stability by reduced Fc dynamics

Masato Kiyoshi, Makoto Nakakido, Abdur Rafique, Minoru Tada, Michihiko Aoyama, Yosuke Terao, Satoru Nagatoishi, Hiroko Shibata, Teruhiko Ide, Kouhei Tsumoto, Yuji Ito and Akiko Ishii-Watabe

Sci Rep, 2023, 13
DOI: 10.1038/s41598-023-43431-0

The Evolution of Antibody‐Drug Conjugates: Toward Accurate DAR and Multi‐specificity

Wenge Dong, Wanqi Wang and Chan Cao

ChemMedChem, 2024, 19
DOI: 10.1002/cmdc.202400109

Studying Intermolecular Interactions in an Antibody-Drug Conjugate Through Chemical Screening and Computational Modeling

Sasha B. Ebrahimi, Xuan Hong, James Ludlow, Dany Doucet and Renuka Thirumangalathu

Journal of Pharmaceutical Sciences, 2023, 112, 2621
DOI: 10.1016/j.xphs.2023.08.002

Imaged capillary isoelectric focusing method development for charge variants of high DAR ADCs

Chuan Leng, Shuwen Sun, Wei Lin, Jorge Alexander Pavon, Lynn Gennaro, Rico C. Gunawan, Xiaodong Bu, Tong Yang and Senwu Li

Analytica Chimica Acta, 2024, 1328, 343176
DOI: 10.1016/j.aca.2024.343176

Drug Molecule Recruitment Empowered by Phase Separation on Cell Membranes In Vivo

Guangfei Duan, Xun Bai, Pengfei Pei, Long Chen, Yunhua Guo, Feng Li, Song Xue and Shi-Zhong Luo

JACS Au, 2025, 5, 2567
DOI: 10.1021/jacsau.5c00197

From concept to clinic: Cutting-Edge advances steering the next wave of antibody–drug conjugates innovation

Imsha Parveen, Anjlina Aqil, Sumit Sharma, Abdul Qadir, Sayed Abdur Rehman, Ashif Iqubal, Khang Wen Goh, Rajath Govind, Mohammad Kashif Iqubal and Prashant Kesharwani

Journal of Drug Delivery Science and Technology, 2026, 120, 108271
DOI: 10.1016/j.jddst.2026.108271

Preparation of an Ultrahigh-DAR PDL1 monoclonal antibody-polymeric-SN38 conjugate for precise colon cancer therapy

Honglei Zhang, Jiali Sun, Yu Zhang, Zhenqian Zhang, Xiaoshuang Wang, Zhilin Liu, Xuefei Zhang, Zhaohui Tang and Xuesi Chen

Biomaterials, 2023, 301, 122285
DOI: 10.1016/j.biomaterials.2023.122285

Antibody–Drug Conjugates: The Past, Present and Future

Gail D. Lewis

Annual Review of Cancer Biology, 2026, 10, 337
DOI: 10.1146/annurev-cancerbio-070524-032954

A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future

Emily Holz, Martine Darwish, Devin B. Tesar and Whitney Shatz-Binder

Pharmaceutics, 2023, 15, 600
DOI: 10.3390/pharmaceutics15020600

Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities

Ritwik Maiti, Bhumika Patel, Nrupesh Patel, Mehul Patel, Alkesh Patel and Nirav Dhanesha

Arch. Pharm. Res., 2023, 46, 361
DOI: 10.1007/s12272-023-01447-0

Antibody‐Drug Conjugates to Treat Bacterial Biofilms via Targeting and Extracellular Drug Release

Anne Tvilum, Mikkel I. Johansen, Lærke N. Glud, Diana M. Ivarsen, Amanda B. Khamas, Sheiliza Carmali, Snehit Satish Mhatre, Ane B. Søgaard, Emma Faddy, Lisanne de Vor, Suzan H. M. Rooijakkers, Lars Østergaard, Nis P. Jørgensen, Rikke L. Meyer and Alexander N. Zelikin

Advanced Science, 2023, 10
DOI: 10.1002/advs.202301340

Antibody–drug conjugates: prospects for the next generation

Meriem Grairi and Marc Le Borgne

Drug Discovery Today, 2024, 29, 104241
DOI: 10.1016/j.drudis.2024.104241